STINGRAY THERAPEUTICS INC
Stingray Therapeutics | Best-in-Class ENPP1 Inhibitor for Cancer Immunotherapy
Houston, United States · Founded 2022 · $5.5M raised
- Headquarters
- Houston, Texas
- Employees
- 1–10
- Founded
- 2022
- Website
- stingraytx.com
- Total Funding
- $5.5M
- Last Round
- $2.0M GrantAug 2025
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
R&D company with 2 SBIR/STTR awards from Department of Health and Human Services.
Summary
STINGRAY THERAPEUTICS INC is a Biotech company based in Houston, United States, founded in 2022. It has raised $5.5M in total across 4 rounds, most recently a $2.0M Grant round in Aug 2025. Investors include National Cancer Institute.
Funding History
Aug 2025
Sign up to see all 4 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/stingray-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/stingray-therapeutics-inc" alt="STINGRAY THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>